Corporate News Report – Cryosite (CTE.AX)
Cryosite Limited (CTE.AX) increased its share price by 4.15 % during a 24‑hour period that ended at 03:27 PM Central Europe on Thursday, 22 April 2026. At the close, one share of Cryosite was priced at approximately AUD 1.25 on major Australian exchanges.
- Shares outstanding: 48.8 million
- Market capitalisation: AUD 61.3 million
- Volume traded in the last 24 hours: about AUD 2.5 k
- Year‑to‑date performance: the stock has risen 6.81 % since the end of March 2026.
- 200‑day simple moving average (SMA): AUD 1.15
- 52‑week range: highest price AUD 1.40 (25 August 2026); lowest price AUD 1.00 (21 May 2026).
Comparative Performance – Other Australian Securities (24‑hour summary)
| Ticker | 24‑hour change | Current price (AUD) | Market cap (AUD) |
|---|---|---|---|
| RNT.AX (Rentau) | –3.23 % | 0.06 | 71.9 million |
| VEE.AX (Veem) | +8.16 % | 0.53 | 71.9 million |
| DGL.AX (/Au) | 0 % | 0.26 | 72.7 million |
| SBZ.AX (Schoolblazer) | 0 % | 0.12 | 70.2 million |
| KRR.AX (King River) | 0 % | 0.05 | 73.4 million |
| P/E ratio (KRR.AX) | – | 4.29 | – |
Company Profile – Cryosite Limited
Cryosite Limited operates in the life‑sciences sector, offering biological storage and sample management services to the medical industry in Australia and New Zealand. The company’s core services include:
- Collection, processing, and storage of cord blood stem cells for private use.
- Management of biological material storage for industries that rely on bioprocessing.
- Handling of temperature‑critical products such as pharmaceuticals and microorganisms.
Cryosite’s operations are accessed through its website, www.cryosite.com , and the company is listed on the ASX All Markets.